Bassam Damaj, President and CEO at APRICUS BIOSCIENCES, INC. (APRI), bought 1,500 shares at $2.69 ($4K) on 2012-08-20, disclosed to the SEC on 2012-08-21.
Open-market purchase of $4k APRI by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| APRI | BUY | 2012-08-23 | $2K | — | Filing → |